Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Boehringer Ingelheim
Healthtrust
Accenture
Chinese Patent Office

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,780,038

« Back to Dashboard

Which drugs does patent 7,780,038 protect, and when does it expire?

Patent 7,780,038 protects QNASL and is included in one NDA.

This patent has seven patent family members in six countries.

Summary for Patent: 7,780,038
Title:Dispensing apparatus with dosage counter
Abstract: A dispensing apparatus (1) comprising a housing containing a dosage counter comprising at least two annular members (11, 13) and a cog (12), each being mounted rotationally. The housing is suitable for receiving, in use, a container (1) containing a product for dispensation. Each actuation of the apparatus causes the first annular member to incrementally rotate which, after a predetermined number of actuations of the apparatus, causes the cog to rotate, the rotation of the cog causing the second annular member to incrementally rotate.
Inventor(s): Ingram; Simon (Northampton, GB), Campling; Nick (Cambridgeshire, GB), Bradley; Duncan (Cambridgeshire, GB)
Assignee: Consort Medical plc (Hertfordshire, GB)
Application Number:11/597,354
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,780,038
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 7,780,038

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Teva Branded Pharm QNASL beclomethasone dipropionate AEROSOL, METERED;NASAL 202813-002 Dec 17, 2014 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Teva Branded Pharm QNASL beclomethasone dipropionate AEROSOL, METERED;NASAL 202813-001 Mar 23, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,780,038

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0411384.1May 21, 2004
PCT Information
PCT FiledMay 23, 2005PCT Application Number:PCT/GB2005/002007
PCT Publication Date:December 01, 2005PCT Publication Number: WO2005/113044

International Family Members for US Patent 7,780,038

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 457763 ➤ Sign Up
Germany 602005019404 ➤ Sign Up
European Patent Office 1758631 ➤ Sign Up
Spain 2339574 ➤ Sign Up
United Kingdom 0411384 ➤ Sign Up
United Kingdom 2414187 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Johnson and Johnson
Argus Health
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.